Exploring Agios' Pioneering Approach at the Intersection of Cancer Metabolism and Genomics | David Schenkein, CEO,Agios Pharmaceuticals Inc . 00:10:00

Share On Facebook Share On Twitter

Discovering the Innovative Approach of Agios at the Nexus of Cancer Metabolism and Genomics, Inspired by Collaborations and Advanced Data Mining Techniques.

Recent Videos